MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D 3in human myeloid leukemia cells leads to bim targeting and inhibition of AraC-induced apoptosis

Cancer Research

Volumn 71, Issue 19, 2011, Pages 6230-6239

  Gocek, Elzbieta ^a,b   Wang, Xuening ^a   Liu, Xiuping ^c   Liu, Chang Gong ^c   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WROC AW   (Poland)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CALCITRIOL; CYTARABINE; MICRORNA; MICRORNA 32; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA PROCESSING; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL DIFFERENTIATION; CYTARABINE; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MEMBRANE PROTEINS; MICRORNAS; MONOCYTES; OLIGORIBONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; U937 CELLS; UP-REGULATION; VITAMIN D;

EID: 80053375836     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1717     Document Type: Article

References (50)

1. Shipley JL, Butera JN. Acute myelogenous leukemia. Exp Hematol 2009;37:649-58.
2. Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y, et al. 1- Alpha,25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 1981;102:937-43. (Pubitemid 12213816)
3. Koeffler HP. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 1983;62:709-21. (Pubitemid 13008656)
4. Studzinski GP, Bhandal AK, Brelvi ZS. A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25- dihydroxycholecalciferol. Proc Soc Exp Biol Med 1985;179:288-95. (Pubitemid 15042873)
5. Wang X, Studzinski GP. Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells. J Cell Biochem 2001;82:68-77.
6. Wang Q, Wang X, Studzinski GP. Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3. J Cell Biochem 2003; 89:1087-101. (Pubitemid 36959378)
7. Pan Z, Hetherington CJ, Zhang DE. CCAAT/enhancer-binding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development. J Biol Chem 1999;274:23242-8.
8. Studzinski GP, Wang X, Ji Y, Wang Q, Zhang Y, Kutner A, et al. The rationale for deltanoids in therapy for myeloid leukemia: role of KSRMAPK- C/EBP pathway. J Steroid Biochem Mol Biol 2005;97:47-55. (Pubitemid 41546213)
9. Marcinkowska E, Garay E, Gocek E, Chrobak A, Wang X, Studzinski GP. Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Exp Cell Res 2006;312:2054-65. (Pubitemid 43850930)
10. 3 exerts dose-dependent dual effects on APL cells. Blood 1997;89:3345-53.
11. Shen Y, Shen ZX, Yan H, Chen J, Zeng XY, Li JM, et al. Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage. Leukemia 2001;15:735-41. (Pubitemid 32492696)
12. 3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea. J Natl Cancer Inst 1986;76:641-8.
13. 3 correlates with reduced rate of maturation of DNA replication intermediates. Cancer Res 1991;51:3451-5.
14. O'Connor L, Strasser A,O'Reilly LA, Hausmann G, Adams JM, Cory S, et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998;17:384-95. (Pubitemid 28045479)
15. Bouillet P, Zhang LC, Huang DC, Webb GC, Bottema CD, Shore P, et al. Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome 2001;12:163-8. (Pubitemid 32147673)
16. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 1979;54:713-33. (Pubitemid 10227870)
17. 3-induced differentiation of AML cells carrying various mutations. Leuk Res 2010; 34:649-57.
18. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-4.
19. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004; 10:1507-17. (Pubitemid 39288185)
20. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008;36:D149-53. (Pubitemid 351149712)
21. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro- RNA targets. Cell 2005;120:15-20. (Pubitemid 40094598)
22. Chen K, Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 2006;38:1452-6. (Pubitemid 44837570)
23. Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle 2009;8:736-41.
24. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007;26:4148-57. (Pubitemid 46920170)
25. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008;68:6162-70.
26. Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002;21:4663-70. (Pubitemid 34984353)
27. Provost P, Dishart D, Doucet J, Frendewey D, Samuelsson B, Radmark O. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J 2002;21:5864-74. (Pubitemid 35315284)
28. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415-9. (Pubitemid 37187272)
29. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004;303:95-8. (Pubitemid 38055779)
30. 3 is associated with increased mitochondrial MCL-1 and RAF-1proteins and reduced release of cytochrome c. Exp Cell Res 1997;235:210-7.
31. Wang X, Patel R, Studzinski GP. hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells. Mol Cancer Ther 2008;7:2798-806.
32. Lombardero M, Kovacs K, Scheithauer BW. Erythropoietin: a hormone with multiple functions. Pathobiology 2011;78:41-53.
33. Wang X, Studzinski GP. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3- induced differentiation of HL60 cells. J Cell Biochem 2001;80:471-82. (Pubitemid 32127462)
34. Marcinkowska E, Kutner A. Side-chain modified vitamin D analogs require activation of both PI 3-K and Erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells. Acta Biochim Pol 2002;49:393-406. (Pubitemid 135686786)
35. 3 and participates in its anti-apoptotic effectandcell cycle control in differentiating HL60 cells. Cell Cycle 2006;5:447-51.
36. Gocek E, Kielbinski M, Marcinkowska E. Activation of intracellular signaling pathways is necessary for an increase in VDR expression and its nuclear translocation. FEBS Lett 2007;581:1751-7. (Pubitemid 46602265)
37. Wang X, Wang TT, White JH, Studzinski GP. Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D3 and is required for optimal cell differentiation. Exp Cell Res 2007;313:3034-45. (Pubitemid 47125886)
38. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 2009;113:396-402.
39. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD. MicroRNA miR-181a correlates with morphological subclass of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007;21:912-6. (Pubitemid 46672066)
40. Cuesta R, Martinez-Sanchez A, Gebauer F. miR-181a regulates capdependent translation of p27Kip1 mRNA in myeloid cells. Mol Cell Biol 2009;29:2841-51.
41. Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, Croce CM, et al. MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 2008;68:2773-80. (Pubitemid 351556275)
42. Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 2007;6:2005-9.
43. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 2007;14:791-8. (Pubitemid 350074067)
44. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3′UTR microRNA recognition elements. Mol Cell 2009;35:610-25.
45. Waf1/Cip1 expression and function in non-malignant prostate cells. Nucleic Acids Res 2011;39:2045-56.
46. 3 receptor. Nucleic Acids Res 2006;34: 543-54.
47. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008;28:2167-74. (Pubitemid 351429964)
48. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A 2008;105:12885-90.
49. Tan TT, Degenhardt K, Nelson DA, Beaudoin B, Nieves-Neira W, Bouillet P, et al. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 2005;7:227-38. (Pubitemid 40568682)
50. Rahmani M, Anderson A, Habibi JR, Crabtree TR, Mayo M, Harada H, et al. The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ ERK1/2 pathways. Blood 2009;114:4507-16.